Trial Profile
A Phase I-II Clinical Trial to Determine Recommended Dose and to Assess the Efficacy, Safety and Pharmacokinetic Profile of Oral Paclitaxel (Oraxol) in Patients With Advanced/Metastatic or Recurrent Gastric Cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Encequidar+paclitaxel
- Indications Gastric cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2011 New trial record